Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Adult Non-infectious Uveitis
NCT07663331Phase 4Recruiting
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in noninfectious uveitis (NIU), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT07663331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07663331.